scholarly journals Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer

JAMA Oncology ◽  
2020 ◽  
Vol 6 (5) ◽  
pp. 661 ◽  
Author(s):  
Naiyer A. Rizvi ◽  
Byoung Chul Cho ◽  
Niels Reinmuth ◽  
Ki Hyeong Lee ◽  
Alexander Luft ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Standard Chemotherapy ◽  
First Line Treatment

Pemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal

2009 ◽  
Vol 10 (11) ◽  
pp. 1031-1032 ◽  
Author(s):  
Panagiota Vrouchou ◽  
Prashanth Kandaswamy ◽  
Elisabeth George ◽  
David Barnett
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document